Bluefin Capital Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Bluefin Capital Management, LLC

  • $1.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$144.95 - $152.29 $49.5 Million - $52 Million
341,250 New
341,250 $51.6 Million
Q1 2021

May 17, 2021
SELL
$64.07 - $91.75 $1.26 Million - $1.81 Million
-19,690 Closed
0 $0
Q4 2020

Feb 10, 2021
SELL
$65.07 - $98.24 $532,207 - $803,504
-8,179 Reduced 29.35%
19,690 $1.69 Million
Q3 2020

Nov 16, 2020
BUY
$59.04 - $77.95 $1.65 Million - $2.17 Million
27,869 New
27,869 $1.81 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email